Company intelligence / Profile preview

Panoxol

Alexandria, Virginia, United Statespanoxol.com ↗

Ownership: Private
Development stage: Commercial

Overview

Panoxol is a US-patented, physician-invented dietary supplement formulated to promote vascular health by increasing peripheral blood flow. Its mechanism centers on supporting healthy nitric oxide levels through the synergistic action of amino acids and herbal ingredients. The product is distributed worldwide by Clinical & Herbal Innovations and is available commercially as an over-the-counter nutraceutical. There are claims of positive outcomes for circulatory support, but no published clinical trial results were identified in the provided sources[1][2].

Therapeutic areas: Cardiovascular
Modalities: Herbal supplementSmall moleculeBotanical extract
Industry: Food & Nutrition

Drug pipeline

1 asset

Panoxol

Commercial

Indications: Cardiovascular health, Vascular health

Beyond the preview

Go deeper on Panoxol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panoxol.

Explore the full profile